X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-17
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs643362-   
Low Rs503261-   
Sales per share (Unadj.) Rs254.4107.6-  
Earnings per share (Unadj.) Rs16.1-27.1-  
Cash flow per share (Unadj.) Rs29.8-22.5-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs194.684.5-  
Shares outstanding (eoy) m126.20168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.32.9 77.8%   
Avg P/E ratio x35.7-11.5 -310.5%  
P/CF ratio (eoy) x19.2-13.9 -138.9%  
Price / Book Value ratio x2.93.7 79.9%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m72,30052,554 137.6%   
No. of employees `00013.34.3 309.9%   
Total wages/salary Rs m6,9603,298 211.0%   
Avg. sales/employee Rs Th2,413.54,231.0 57.0%   
Avg. wages/employee Rs Th523.2768.3 68.1%   
Avg. net profit/employee Rs Th152.4-1,066.1 -14.3%   
INCOME DATA
Net Sales Rs m32,10618,164 176.8%  
Other income Rs m226127 177.4%   
Total revenues Rs m32,33218,291 176.8%   
Gross profit Rs m4,448-3,148 -141.3%  
Depreciation Rs m1,730784 220.6%   
Interest Rs m241492 48.9%   
Profit before tax Rs m2,703-4,296 -62.9%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m675268 251.5%   
Profit after tax Rs m2,028-4,577 -44.3%  
Gross profit margin %13.9-17.3 -79.9%  
Effective tax rate %25.0-6.2 -399.7%   
Net profit margin %6.3-25.2 -25.1%  
BALANCE SHEET DATA
Current assets Rs m17,34013,303 130.3%   
Current liabilities Rs m9,5597,485 127.7%   
Net working cap to sales %24.232.0 75.7%  
Current ratio x1.81.8 102.1%  
Inventory Days Days100111 90.4%  
Debtors Days Days57124 45.9%  
Net fixed assets Rs m20,7797,754 268.0%   
Share capital Rs m25284 299.3%   
"Free" reserves Rs m24,4990-   
Net worth Rs m24,55314,256 172.2%   
Long term debt Rs m3,5175,010 70.2%   
Total assets Rs m39,59526,932 147.0%  
Interest coverage x12.2-7.7 -158.1%   
Debt to equity ratio x0.10.4 40.8%  
Sales to assets ratio x0.80.7 120.2%   
Return on assets %5.7-15.2 -37.8%  
Return on equity %8.3-32.1 -25.7%  
Return on capital %10.5-19.8 -52.9%  
Exports to sales %48.60-   
Imports to sales %14.20-   
Net fx Rs m9,7900-   
CASH FLOW
From Operations Rs m2,7641,550 178.3%  
From Investments Rs m-1,432-476 300.7%  
From Financial Activity Rs m-1,5914,547 -35.0%  
Net Cashflow Rs m-2595,621 -4.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.99 Rs / ZAR

Compare IPCA LABS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: CIPLA  AJANTA PHARMA  SUVEN LIFE  ALEMBIC PHARMA  FDC LTD.  



Today's Market

Sensex Opens Higher; Consumer Durables & Bank Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.8% while the Hang Seng is down 0.4%.

Related Views On News

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jun 21, 2018 09:59 AM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS